Role of IL-4gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lu, Yu ^a   Wu, Zhitong ^b   Peng, Qiliu ^a   Ma, Liping ^a   Zhang, Xiaolian ^a   Zhao, Jiangyang ^a   Qin, Xue ^a   Li, Shan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Guigang People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; DNA SEQUENCE; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IL 4 GENE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; LIVER TUMOR; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

INTERLEUKIN 4;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-4; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84907807877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110061     Document Type: Article

References (52)

1. Liaw YF, Chu CM (2009) Hepatitis B virus infection. Lancet 373:582-592.
2. Lavanchy D (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 Suppl 1:S1-3.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529-538.
4. Yin J, Xie J, Liu S, Zhang H, Han L, et al. (2011) Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 106:81-92.
5. Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
6. Chen L, Zhang Q, Chang W, Du Y, Zhang H, et al. (2012) Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma. Eur J Cancer 48:1977-1987.
7. Chemin I, Zoulim F (2009) Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 286:52-59.
8. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, et al. (2011) Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 17:4258-4270.
9. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-411.
10. Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, et al. (2007) Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer 43:762-768.
11. Luzina IG, Keegan AD, Heller NM, Rook GA, Shea-Donohue T, et al. (2012) Regulation of inflammation by interleukin-4: a review of "alternatives". J Leukoc Biol 92:753-764.
12. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
13. Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287-292.
14. Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, et al. (2013) The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013:187204.
15. Jiang H, Harris MB, Rothman P (2000) IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 105:1063-1070.
16. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, et al. (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152-1156.
17. Naslednikova IO, Konenkov VI, Ryazantseva NV, Novitskii VV, Tkachenko SB, et al. (2007) Role of genetically determined production of immunoregulatory cytokines in immunopathogenesis of chronic viral hepatitides. Bull Exp Biol Med 143:706-712.
18. Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, et al. (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430-1440.
19. Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, et al. (2005) Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 118:1604-1609.
20. Zheng Z, Li X, Li Z, Ma XC (2013) IL-4-590C/T polymorphism and susceptibility to liver disease: a meta-analysis and meta-regression. DNA Cell Biol 32:443-450.
21. Cui W, Sun CM, Deng BC, Liu P (2013) Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a meta-analysis. Gene 525:35-40.
22. Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC (2009) Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 30:758-762.
23. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507-539.
24. Peng Q, Qin X, He Y, Chen Z, Deng Y, et al. (2013) Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol 16:1-4.
25. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
26. Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98.
27. Li Z, Zhang Z, He Z, Tang W, Li T, et al. (2009) A partition-ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 19:519-523.
28. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
29. Tang ZY YQ, Feng XL, Zhou L, Zhang YL, Chen B (2009) Association between IL-4 C+33T and serum levels of IL-4 and atherothrombotic cerebral infarction in Chinese Han. Stroke and nevous diseases 16:11-14.
30. Yin J, Zhang H, He Y, Xie J, Liu S, et al. (2010) Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev 19:777-786.
31. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
32. Yu MC, Yuan JM (2004) Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127:S72-78.
33. Zeng Z (2014) Human genes involved in hepatitis B virus infection. World J Gastroenterol 20:7696-7706.
34. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701-738.
35. Kelly-Welch A, Hanson EM, Keegan AD (2005) Interleukin-13 (IL-13) pathway. Sci STKE 2005: cm8.
36. Chomarat P, Banchereau J (1998) Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17:1-52.
37. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD (2003) Interleukin-4 and interleukin-13 signaling connections maps. Science 300:1527-1528.
38. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, et al. (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132:259-272.
39. Iseki M, Omori-Miyake M, Xu W, Sun X, Takaki S, et al. (2012) Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4. Int Immunol 24:183-195.
40. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, et al. (2007) Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res 150:116-121.
41. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, et al. (2009) Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 15:5610-5619.
42. Liu Q, Long H., Wang J. G., Du J. H. (2007) Relationship between genetic polymorphisms of interleukin-4 (IL-4), interleukin-4 receptor a chain with susceptibility to HBVinduced liver cirrhosis. Chin J Integr Tradit West Med Liver Dis 17:211-213.
43. Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, et al. (2005) Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J 26:1604-1069.
44. Wang K, Shi CW, Gao Y, Yu ZH, Ning T, et al. (2006) The association of IL-2 and IL-4 polymorphisms and hepatitis B in population of north China. Chin J Curr Adv Gen Surg 9:171-176.
45. Gao QJ, Sun DX, Zhang YH, Chen SP, Wang XH, et al. (2012) Association of IL-4-589 polymorphisms with chronic hepatitis B and hepatitis C virus infection. Med Pharm J Chin People's Liberation Army 24:8-10.
46. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, et al. (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103:740-748.
47. Puthothu B, Krueger M, Forster J, Heinzmann A (2006) Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 193:438-441.
48. Suppiah V, Goris A, Alloza I, Heggarty S, Dubois B, et al. (2005) Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Int J Immunogenet 32:383-388.
49. Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ (2005) Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19:93-98.
50. Wu MC, Huang CM, Tsai JJ, Chen HY, Tsai FJ (2003) Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus 12:21-25.
51. Takabayashi A, Ihara K, Sasaki Y, Kusuhara K, Nishima S, et al. (1999) Novel polymorphism in the 59-untranslated region of the interleukin-4 gene. J Hum Genet 44:352-353.
52. Wierenga EA, Messer G (2000) Regulation of interleukin 4 gene transcription: alterations in atopic disease? Am J Respir Crit Care Med 162:S81-85.